You are here

INX-189

Pipeline Setback at Bristol-Myers

Yahoo/Zacks

Sat, 08/4/12 - 12:14 pm

Bristol-Myers Squibb

Bristol to buy Inhibitex for hepatitis C treatment

Reuters

Sun, 01/8/12 - 12:45 pm

Bristol-Myers Squibb

Inhibitex Shares Whipsawed by Cautious Analyst Comment

TheStreet.com

Wed, 01/4/12 - 03:14 pm

Inhibitex Shares Got Crushed: What You Need to Know

Motley Fool

Sat, 12/17/11 - 11:26 am

4 Reasons Inhibitex Is No Longer A Good Buy

Seeking Alpha

Wed, 12/7/11 - 11:42 am

Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial

Yahoo/Fly on the Wall

Tue, 11/29/11 - 10:20 am

Inhibitex's Future Looks Promising

Seeking Alpha

Mon, 11/7/11 - 11:09 am

Inhibitex Investors: Why Shares Popped 115%

Motley Fool

Sun, 11/6/11 - 11:57 am

Inhibitex Soars as Investors See Another Pharmasset in the Making

TheStreet.com

Fri, 11/4/11 - 09:29 am

Inhibitex: Recent Price Action Sees Pressure To Cover Mounting

Seeking Alpha

Sun, 10/9/11 - 03:59 pm

Buying Into a Hot Hepatitis C Drug Market

Minyanville

Thu, 08/25/11 - 03:44 pm

Four Biotechs to Watch Early This Week

Seeking Alpha

Sun, 03/6/11 - 12:35 pm

ImmunoCellular Therapeutics

glioblastoma multiforme

Jazz Pharmaceuticals

Repros Therapeutics

Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189

BusinessWire

Sun, 01/9/11 - 06:11 pm

Trials start on potent new hepatitis C drug

Times of India, India

Sat, 05/15/10 - 01:13 pm